Skip to content

Clinical trials

Leiomyosarcoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20082
20112
20121
20151
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC10
Eli Lilly and Company2
AGO Study Group1
Heidelberg University1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
North Eastern German Society of Gynaecological Oncology1
PTC Therapeutics1
PharmaMar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma19
Liposarcoma12
Sarcoma11
Histiocytoma, Malignant Fibrous10
Fibrosarcoma9
Hemangiosarcoma9
Sarcoma, Synovial9
Neurofibrosarcoma8
Rhabdomyosarcoma8
Sarcoma, Alveolar Soft Part3

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.